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ABSTRACT 
Thyroid disease especially Hypothyroidism is one of the commonest endocrine disorders 
worldwide and its prevalence of is increasing day by day. In allopathic system hypothyroidism is 
managed by replacement therapy with L-thyroxin which appears effective in restoring 
biochemical euthyroidism. However, studies continue to show problems in the management of 
this condition. Many patients report not feeling well with persistent symptoms despite adequate 
T4 replacement therapy. It has become necessary to find alternative medicine for managing 
hypothyroid symptoms. The main underlying pathology in Hypothyroidism is Hypometabolism in 
the tissues. This hypometabolism can be correlated to Mandagni in Ayurveda. Keeping this in 
mind we can plan the treatment of hypothyroidism in the line of treatment of Mandagni. In the 
treatment of Mandagni, on effective Ayurvedic formulation is Trikatu Churna. In this clinical study 
we have used Trikatu churna, as a dietary supplement in 30 patients from the OPD of Govt. 
Ayurvedic College and Hospital, Guwahati, to study its potential in the management of 
hypothyroidism. The statistical analysis of the data in trial group with Trikatu churna showed the 
value at 1.86 with level of significance at 1% (p<0.10). The Result of the clinical trial signifies that 
Trikatu churna is effective in the management of hypothyroidism. 
KEYWORDS: Hypothyroidism, Mandagni, Trikatu churna, clinical symptom, biochemical 
euthyroidism. 
INTRODUCTION
 Thyroid disorders mainly Hypothyroidism is 
a very common problem amongst the general 
population worldwide and in India as well. It has 
been reported that in India alone about 42 million 
people suffer from thyroid disorders[1]. The growing 
cause of concern is that the incidence is increasing 
day by day. 
 Hypothyroidism is a disease involving the 
thyroid gland where there is hypo-functioning of 
tissue metabolism. Diagnosis and treatment of 
hypothyroidism is often considered simple with 
hormone replacement therapy. However, studies 
continue to show problems in the management of 
this condition. Many patients on thyroid hormone 
replacement are either under-replaced or over-
replaced[2]. A significant number of patients on 
thyroid hormone replacement report not feeling well 
with persistent symptoms despite adequate T4 
replacement therapy and thyroid hormone level 
within normal limit. Most often the symptoms of 
hypothyroidism like weight gain, lethargy, fatigue, 
muscle aches, depressed mood, decreased memory 
function, hair fall etc. persist in the patient [3]. A 
recent community study provided evidence to 
indicate that patients on thyroxin replacement even 
those with a normal serum TSH display significant 
impairment in psychological well-being compared 
with controls of similar age and sex. [4] 
  In the Ayurvedic classics there is no direct 
mention of the disease hypothyroidism. A passing 
reference to the disease Galaganda compared with 
goitre is found in most of them. Another possible 
correlation is the disease Kaphaja Soth which has 
features similar to myxedema. Since in 
Hypothyroidism the main underlying pathology is 
hypometabolism, it seems to fit into the concept of 
Mandagni given in Ayurveda.   
 However, as regards to treatment of 
hypothyroidism, there is no specific and effective 
classical medicine. Apart from Kanchanar guggulu, 
there seems to be no other choice. 
 To overcome this lacuna in this clinical study 
we have used Trikatu churna as a dietary supplement 
to find out its potential in the management of 
hypothyroidism correlating the concept of hypo 
metabolism in hypothyroidism with Mandagni.  
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STUDY DESIGN 
The study design is a randomized control trial 
cleared by the Institutional Ethical Committee, Govt. 
Ayurvedic College. A total no of 60 patients of 
hypothyroidism were randomly selected from the 
OPD of Govt. Ayurvedic College and Hospital, 
Guwahati-14, Assam, India after scrutinizing the 
inclusion and exclusion criteria as mentioned below.  
Inclusion criteria: All hypothyroid patients 
with TSH level ≤ 10mlU/L. Patient of any sex, religion 
community, socio-economic status, education and age 
who satisfy the required criteria and willing to take 
part in the trial. 
 Exclusion criteria: Critically ill patients. 
The patients were divided into 2 groups of 30 
patients each. 
 A) Group A: Trikatu churna as a supplement with 
diet of the patient along with dietary advice specific 
for hypothyroidism. 
 B) Group B: conventional treatment with thyroxine 
sodium (1.6µgm/kg/day).  
MATERIALS 
 i) Consent form, 
 ii) Performa (case record form) 
 iii) Trikatu churna : equal quantity of - 
a) Pippali - Piper longum 
b) Marich – Piper nigrum 
c) Sunthi – gingiber officinalis 
METHOD 
A detailed clinical examination was done 
before and after the study using a prepared case 
record form. The patients in group A are advised to 
take the trial supplement Trikatu churna (1½ - 3gms) 
mixed with their regular meal like dal, sabji etc. with 
additional dietary advice specific for hypothyroidism. 
The patients in group B are prescribed conventional 
treatment with levothyroxine sodium in appropriate 
dose (1.6µgm /kg/day).  
 
Trial 
supplement 
Trikatu churna (sunthi+ pippali+ 
marich, in equal quantity) 
Quantity 1⅟₂ - 3gms 
Duration of 
study 
90 days 
Criteria for assessment of result 
 The selected patients in both the groups are advised 
to take their respective treatment advice and asked 
to come for follow up every 30 days till the entire 
study duration of 90 days. The result is assessed on 
the basis of Objective parameter before and after the 
treatment. 
Objective parameter:  
1. Estimation of serum TSH level. 
2. Estimation of T3  
3. Estimation of T4 
RESULT 
 During the study, the patients were first 
screened for their thyroid profile (TSH, T3 & T4 ) and 
the result recorded. After 90 days of treatment, the 
thyroid profile of the patients was assessed again. It 
was observed that in group A, where Trikatu churna 
was given as supplement with diet, the patients 
regained euthyriod state i.e., their TSH level came 
down to within normal limits. Along with it the 
associated symptoms of Hypothyroidism like weight 
gain, constipation, indigestion, lethargy, fatigue, 
muscle aches, depressed mood, was also relieved to a 
great extent. In group B, where levothyroxine sodium 
in appropriate dose (1.6µgm/kg/day) was given, the 
euthyrid status was achieved but symptoms 
associated with hypothyroidism remained in most of 
the patients. The T3 and T4 value before treatment 
was within normal limits in most of the patients and 
didn’t show significant change after treatment and 
was within normal limits. Comparison of the efficacy 
of treatment in both the groups showed that Trikatu 
churna is less effective than levothyroxine in 
achieving the euthyroid state. But, it is undoubtedly 
an effective replacement for levothyroxine keeping in 
mind its effect in relieving the associated symptoms 
of hypothyroidism. 
The statistical analysis of the data to study the efficacy of treatment is as below: 
Table 1: Effect of treatment in trial group (Group A) 
Group n Mean(X) SD SE T value P value 
A 29 1.75 5.04 0.94 1.86 <0.10 
The statistical analysis of the data in trial group with Trikatu churna (Group A) showed t value at 1.86 with 
level of significance at 1% (p<0.10) signifying that the efficacy of treatment in the trial group is significant. 
N.B: The sample size in the trial group though initially was taken as 30, 1 sample had to be omitted 
while doing the statistical analysis as its inclusion showed aberrant results. So for the analysis of the data with 
paired t –test in Group A, sample size (n) was taken as 29.  
Das Nabanita, Choudhary Kuldeep, Kanika Goswami. Trikatu Churna in the Management of Hypothyroidism 
     Available online at: http://ijapr.in  73 
Table 2: Effect of treatment in control group (Group B) 
Group  n Mean(X) SD  SE  t value P value 
B  30 4.74 3.34  0.61  7.8 <0.01 
Analysis of the statistical data in the control group with hormone replacement therapy (Group B) 
showed t value at 7.8 with level of significance at 0.1% (p<0.01). Thus it is seen that the efficacy of treatment in 
the control group is highly significant.  
Table 3: Comparison of effect of treatment in trial group (Group A) and control group (Group B) 
Group  n Mean(X) df Combined 
variance of SD 
SE t value P value 
A  29 1.75  
57 
 
4.2 
 
1.1 
 
-2.99 
 
<0.01 B  30 4.74 
Comparison of the statistical data of the two groups gives the t value at 2.99 corresponding to a P value 
<0.01. Thus it can be inferred that the efficacy of treatment in the control group with hormone replacement 
therapy (Group B) is more significant than in the trial group with Trikatu churna. 
DISCUSSION AND CONCLUSION 
  From the clinical trial done with Trikatu 
churna on patients of Hypothyroidism, positive 
response has been obtained. The result observed in 
the patients in the clinical trial it has shows that 
Trikatu churna reduces body weight, puffiness from 
eyes, increases the digestive capacity. Patients also 
experienced decrease in lethargy and feeling of 
heaviness. In all the 30 patients there is a 
considerable decrease in the TSH level as well. 
  Trikatu is an effective formulation in treating 
Mandagni. This has been mentioned in the classical 
texts of Ayurveda by various scholars. 
  Trikatu churna is an Ayurvedic poly herbal 
preparation of Pippali (Piper longum L., fruit), Marich 
(Piper nigrum L., fruit) and Sunthi (Zingiber officinale 
Rosc, rhizome), all in equal ratio. It is one of the most 
commonly used ingredients in most Ayurvedic 
formulations. Synonyms of Trikatu include Katutrik, 
Triusan, Vyos. According to Vhabprakash Trikatu 
increases Agni, relieves respiratory disorders, skin 
disease, Gulma, Prameha, Kapha, Sthoulya, Meda, 
Slipad and Pinas. [5] 
 Trikaṭu is predominantly having Uṣṇa, Tikṣṇa, 
Laghu, Ruksa guṇa, Kaṭu rasa, Kaṭu vipaka & Uṣṇa 
virya. Hence it exhibits Kapha-vata shamaka, 
Deepana, Pachana, Srotovishodhana & Shothahara 
properties. In Ayurvedic tradition, Trikatu is known 
as Heating Formula. Its Thermogenic action or Usna 
guna promotes Agni or digestive fire which burns the 
harmful toxins and revitalizes the metabolism. Some 
important benefits of Trikatu are: it promotes healthy 
digestion, improves all gastric functions, and 
increases food absorption. It reduces congestion in 
digestive tract. It is recommended for poor digestion 
and poor appetite. It is also recommended for 
improving lung functions. It helps in reducing excess 
weight and increases vitality etc. Sunthi is one of the 
best herbs which rejuvenate the whole body, this is 
the reason it is also called as Vishvabhaishjya which 
means the medicine of the world. Maricha or black 
pepper is said to have Pramathi Guna i.e., it forcefully 
expels out the toxins from the body [6,7,8]. Pippali 
increases the absorption of selenium, a trace element 
required for deiodinase reaction of the thyroid 
hormone necessary for bioactivity of the hormone [9] . 
 The active principle of Trikatu is piperine. 
Piperine (1-piperoyl piperidine), an amide alkaloid, is 
mainly responsible for enhancing the bioavailability 
of concurrently administered drugs. This mechanism 
is still being studied, but piperine is known to inhibit 
the enzymes P-glycoprotein and CYP3A4 in humans. 
These enzymes are involved in the metabolism and 
transport of various metabolites [10]. Piperine 
interacts with proteins embedded in the cell 
membrane by stimulating leucine amino peptidase 
and glycyl-glycine dipeptidase activity. This suggests 
that piperine could modulate the cell membrane 
dynamics related to passive transport mechanism 
due to its apolar nature by interacting with 
surrounding lipids and hydrophobic domain of 
cellular proteins. The improved bio availability of 
nutrients by the piperine is perhaps due to its thermo 
nutrient action or thermogenic action. Bioavailability 
enhancing action of drugs is partly due to 
enhancement of blood supply in enteric vessels as a 
result of local vasodilatation by enhancing drug 
transport [11]. 
 Analysing the properties of Trikatu churna, it 
can be concluded that the possible mode of action of 
the trial drug Trikatu churna may be due to its 
property of thermogenesis and its action as 
bioavailability enhancer. According to Ayurveda also 
the Usna guna and Katu rasa of Trikatu stimulates 
Pitta. It has predominance of Agni, Vayu and Akash 
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mahabhut which is responsible for Kapha saman. It 
has Deepaniya and Pachaniya property and it 
promotes Agni. Besides the Tikshna property of 
Trikatu ensures tissue penetration thereby showing 
its action in Mandagni at the Dhatwagni and Bhutagni 
level. So in hypothyroidism where there is 
hypometabolism, Trikatu churna shows promising 
results by reversing the hypometabolism in the 
tissues and thereby, by feedback mechanism 
normalising the TSH. Thus Trikatu churna can be 
used as a dietary supplement in the management of 
hypothyroidism. However further research is 
required to study how Trikatu churna enhances 
metabolism in the tissues effecting the thyroid 
hormone levels. 
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